233 related articles for article (PubMed ID: 10554098)
21. Nanoparticulate systems for brain delivery of drugs.
Kreuter J
Adv Drug Deliv Rev; 2001 Mar; 47(1):65-81. PubMed ID: 11251246
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).
Zara GP; Cavalli R; Fundarò A; Bargoni A; Caputo O; Gasco MR
Pharmacol Res; 1999 Sep; 40(3):281-6. PubMed ID: 10479474
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles.
Steiniger SC; Kreuter J; Khalansky AS; Skidan IN; Bobruskin AI; Smirnova ZS; Severin SE; Uhl R; Kock M; Geiger KD; Gelperina SE
Int J Cancer; 2004 May; 109(5):759-67. PubMed ID: 14999786
[TBL] [Abstract][Full Text] [Related]
24. Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity.
Olivier JC; Fenart L; Chauvet R; Pariat C; Cecchelli R; Couet W
Pharm Res; 1999 Dec; 16(12):1836-42. PubMed ID: 10644071
[TBL] [Abstract][Full Text] [Related]
25. Intranasal administration of pullulan-based nanoparticles for enhanced delivery of adriamycin into the brain:
Zhu J; Zou J; Mu C; Yang W; Gu M; Lin J; Song X; Zheng H; Li F
Pharmazie; 2019 Jan; 74(1):39-46. PubMed ID: 30782249
[TBL] [Abstract][Full Text] [Related]
26. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
Alyautdin RN; Petrov VE; Langer K; Berthold A; Kharkevich DA; Kreuter J
Pharm Res; 1997 Mar; 14(3):325-8. PubMed ID: 9098875
[TBL] [Abstract][Full Text] [Related]
27. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats.
Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X
J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669
[TBL] [Abstract][Full Text] [Related]
28. Design of pH-responsive nanoparticles of terpolymer of poly(methacrylic acid), polysorbate 80 and starch for delivery of doxorubicin.
Shalviri A; Chan HK; Raval G; Abdekhodaie MJ; Liu Q; Heerklotz H; Wu XY
Colloids Surf B Biointerfaces; 2013 Jan; 101():405-13. PubMed ID: 23010048
[TBL] [Abstract][Full Text] [Related]
29. HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles.
Alhareth K; Vauthier C; Gueutin C; Ponchel G; Moussa F
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():128-32. PubMed ID: 22341684
[TBL] [Abstract][Full Text] [Related]
30. Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues.
Zara GP; Cavalli R; Bargoni A; Fundarò A; Vighetto D; Gasco MR
J Drug Target; 2002 Jun; 10(4):327-35. PubMed ID: 12164381
[TBL] [Abstract][Full Text] [Related]
31. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
Gelperina S; Maksimenko O; Khalansky A; Vanchugova L; Shipulo E; Abbasova K; Berdiev R; Wohlfart S; Chepurnova N; Kreuter J
Eur J Pharm Biopharm; 2010 Feb; 74(2):157-63. PubMed ID: 19755158
[TBL] [Abstract][Full Text] [Related]
32. Influence of the surfactant concentration on the body distribution of nanoparticles.
Araujo L; Löbenberg R; Kreuter J
J Drug Target; 1999; 6(5):373-85. PubMed ID: 10342385
[TBL] [Abstract][Full Text] [Related]
33. Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy.
Siegal T; Horowitz A; Gabizon A
J Neurosurg; 1995 Dec; 83(6):1029-37. PubMed ID: 7490617
[TBL] [Abstract][Full Text] [Related]
34. Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects.
Hekmatara T; Bernreuther C; Khalansky AS; Theisen A; Weissenberger J; Matschke J; Gelperina S; Kreuter J; Glatzel M
Clin Neuropathol; 2009; 28(3):153-64. PubMed ID: 19537130
[TBL] [Abstract][Full Text] [Related]
35. Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.
Miyazawa T; Nakagawa K; Harigae T; Onuma R; Kimura F; Fujii T; Miyazawa T
Int J Nanomedicine; 2015; 10():7223-30. PubMed ID: 26664113
[TBL] [Abstract][Full Text] [Related]
36. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351
[TBL] [Abstract][Full Text] [Related]
37. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
[TBL] [Abstract][Full Text] [Related]
38. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.
Alyautdin RN; Tezikov EB; Ramge P; Kharkevich DA; Begley DJ; Kreuter J
J Microencapsul; 1998; 15(1):67-74. PubMed ID: 9463808
[TBL] [Abstract][Full Text] [Related]
39. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
[TBL] [Abstract][Full Text] [Related]
40. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]